Get the latest Science News and Discoveries
Why pharma firms are betting billions on psychedelic drugs despite setbacks
Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.
None
Or read this on Nature

